On admission, empirical broad-spectrum antimicrobial treatment was initiated to cover Mycobacterium tuberculosis and the most common pathogens of bacterial meningitis and rhomboencephalitis; therefore, isoniazid, pyrazinamide, rifampicin, and phenytoin were formed.